Electroacupuncture Combined With Fast-track Perioperative Program for Laparoscopic Colorectal Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04090073|
Recruitment Status : Recruiting
First Posted : September 16, 2019
Last Update Posted : October 4, 2019
Background: The investigators' previous study demonstrated that electroacupuncture (EA) reduces the duration of postoperative ileus and hospital stay after laparoscopic colorectal surgery within a traditional perioperative care setting. Recent evidence also suggested that a 'fast-track' (FT) perioperative program may help accelerate recovery after colorectal surgery. It is uncertain whether the combination of EA and FT program will result in faster recovery after laparoscopic colorectal surgery when compared with FT program alone.
Objectives: To compare the efficacy of EA combined with FT program versus FT program alone in reducing the duration of postoperative ileus and hospital stay after laparoscopic colorectal surgery
Design: Prospective randomized trial.
Subjects: 72 consecutive patients undergoing elective laparoscopic resection of colonic and upper rectal cancer without conversion will be recruited.
Interventions: Patients will be randomly allocated to one of the two groups receiving either EA + FT program, or FT program alone.
Outcome measures: Primary outcome: time to defecation. Secondary outcomes: duration of hospital stay, time to resume diet, pain scores, analgesic requirement, morbidity, quality of life, and medical costs.
Conclusions: This study serves as a good example that illustrates an integrated approach in combining Chinese and Western models of health care. It will provide evidence-based clarification of the role of EA in enhancing recovery after laparoscopic colorectal surgery within a FT perioperative care setting. As laparoscopic colorectal surgery has been shown to have a higher direct cost than the open counterpart, a faster postoperative recovery may help reduce the financial burden to the hospital/healthcare system.
|Condition or disease||Intervention/treatment||Phase|
|Postoperative Ileus||Procedure: Electroacupuncture Other: Fast-track Perioperative program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||72 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Electroacupuncture Combined With Fast-track Perioperative Program for Reducing Duration of Postoperative Ileus and Hospital Stay After Laparoscopic Colorectal Surgery: A Randomized Controlled Trial|
|Actual Study Start Date :||October 1, 2019|
|Estimated Primary Completion Date :||October 2020|
|Estimated Study Completion Date :||October 2020|
Experimental: Electroacupuncture Plus Fast-track Perioperative Program
Patients who are randomized to the intervention arm will receive Electroacupuncture combined with Fast-track program. Each session of Electroacupuncture will last for 20 minutes. The patients will undergo one session of Electroacupuncture daily from day 1 till day 4, or until the time when the primary outcome has occurred, whichever is earlier.
Other: Fast-track Perioperative program
Active Comparator: Fast-track Perioperative Program
Patients who are randomized to the control arm will receive Fast-track program alone.
Other: Fast-track Perioperative program
- Time to defecation [ Time Frame: Up to 1 month ]Measured in hours, from the time the laparoscopic surgery ends till the first observed passage of stool.
- Total postoperative hospital stay [ Time Frame: Up to 1 month ]Including hospital stay of patients who are readmitted within 30 days after surgery
- Time of first passing flatus reported by the patients [ Time Frame: Up to 1 month ]
- Time that the patients tolerated solid diet [ Time Frame: Up to 1 month ]Time that the patients tolerated solid diet (any food that required chewing) without vomiting or experiencing significant nausea 4 hours following the meal
- Time to walk independently [ Time Frame: Up to 1 month ]
- Pain scores on visual analog scale [ Time Frame: Up to 1 month ]From 0 which implies no pain at all, to 100 which implies the worst pain imaginable, on the first 3 postoperative days
- Postoperative 30-day morbidity [ Time Frame: Up to 1 month ]Defined by the Clavien-Dindo classification of surgical complications
- Incidence rate of adverse events related to electroacupuncture [ Time Frame: Up to 1 month ]
- Readmission rate [ Time Frame: Up to 1 month ]
- Quality of life scores measured by Short Form 36 (SF-36) Health Survey at 2 and 4 weeks after surgery [ Time Frame: Up to 1 month ]SF-36 Health Survey is a 36-item, patient-reported survey of patient health. It consists of eight scaled scores, which are the weighted sums of the questions in their section. The eight sections are: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
- Quality of life scores measured by European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaires at 2 and 4 weeks after surgery [ Time Frame: Up to 1 month ]EORTC QLQ-C30 is a generic questionnaire for assessment of quality of life (QoL) in cancer patients. It includes 30 items, 24 of which are combined to form a global QoL scale, five functional scales (physical, role, emotional, cognitive, and social), and three symptom scales (fatigue, nausea/vomiting, and pain). The other six single items evaluate dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties. All questionnaires responses and scores will be linearly transformed to a 0-100 scale. A higher score on the global QoL and functional scales represents a higher level of QoL and functioning, whereas a higher score on the symptom scales/items represents a higher degree of symptoms or dysfunction.
- Quality of life measured by European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CR38 questionnaires at 2 and 4 weeks after surgery [ Time Frame: Up to 1 month ]EORTC QLQ-CR38 is a specific questionnaire module specifically designed for assessment of quality of life (QoL) in patients with colorectal cancer. It consists of 38 items covering symptoms and side effects related to different colorectal cancer treatment modalities. The module contains four functional scales (body image, sexual functioning, sexual enjoyment, and future perspective) and eight symptom scales/items (micturition problems, chemotherapy side effects, gastrointestinal tract symptoms, male sexual problems, female sexual problems, defecation problems, stoma-related problems, and weight loss). All questionnaires responses and scores will be linearly transformed to a 0-100 scale. A higher score on the global QoL and functional scales represents a higher level of QoL and functioning, whereas a higher score on the symptom scales/items represents a higher degree of symptoms or dysfunction.
- Direct/indirect medical costs and out-of-hospital economic costs [ Time Frame: Up to 1 month ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04090073
|Contact: Simon SM Ng, MDfirstname.lastname@example.org|
|Contact: Tony WC Mak, MDemail@example.com|
|Prince of Wales Hospital, The Chinese University of Hong Kong||Recruiting|
|Hong Kong, China|
|Contact: Simon SM Ng, MD (852) 3505 1495 firstname.lastname@example.org|
|Contact: Tony WC Mak, MD (852) 3505 1495 email@example.com|
|Principal Investigator: Simon SM Ng, MD|
|Sub-Investigator: Tony WC Mak, MD|
|Principal Investigator:||Simon SM Ng, MD||Chinese University of Hong Kong|